House Commerce/Health Subcommittee schedules FDA reform hearing for Feb. 27.
This article was originally published in The Tan Sheet
Executive Summary
HOUSE FDA REFORM HEARING SLATED FOR FEB. 27 before Rep. Michael Bilirakis' (R-Fla.) Commerce/Health Subcommittee. The hearing will likely focus on third-party review, House Commerce Committee Chairman Thomas Bliley (R-Va.) told a Feb. 7 meeting on FDA reform sponsored by the Progress & Freedom Foundation in Washington, D.C. Speaking by telephone, Bliley indicated that the hearing will be the first of a series on FDA reform to be held by the Health and Oversight & Investigations subcommittees.